GPT and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, the CML+apoA-I+CIGB-258 group showed the lowest AST and ALT levels (253 IU/L and 147 IU/L, respectively), which were 51% and 42% lower than those of the CML+PBS group, respectively.